Third, although we have demonstrated that plasma levels of ACY1, GHR, and OMD are to some extent specific to PD, in that they are not similarly changed in ALS, it is still possible that some of these protein biomarkers may show similar changes in other neurodegenerative diseases that were not tested. This evidence concerns the gene GHR and Parkinson disease.